We couldn’t find any content because your search may be too narrow.
Consider broadening your search
marketwatch.comUPDATE: Viking Therapeutics stock rockets 140% after positive trial of non-alcoholic fatty liver treatmentViking Therapeutics Inc. stock rocketed 140% in premarket trade Tuesday, after the company reported positive results in a mid-stage trial of a treatment for non-alcoholic fatty liver disease, or NAFLD. The San Diego-based biotech said the Phase 2 trial of VK2809, its novel liver-selective thyroid receptor beta agonist, in patients NAFLD and elevated low-density lipoprotein cholesterol met its primary goal of reducing LDL-C compared with placebo. It also met its secondary endpoint of showing significant reductions in liver fat content. Madrigal Pharmaceuticals Inc. , a rival company working on the same class of drug, had shares drop 12.5% in premarket trade. Viking shares have gained 156% in 2018 through Monday, while the S&P 500 has gained 8%.
mudabure.comTim Conway's daughter gets temporary restraining order against his wife over star's careTim Conway’s wife and daughter are at odds over his medical treatment as the “Carol Burnett Show” star suffers from dementia. A rep for Conway's daughter Kelly told Fox News Friday she received a temporary restraining order to stop his current wife's plans to move the ailing comic from his current medical facility. 'My brothers and I are extremely happy that the plan to move our dad by his wife has been temporarily stopped by a court order today,' wrote Kelly. 'We are grateful to the judge for taking this matter seriously by considering all the evidence before making a7
marketresearchfuture.comYeast Infection Market Research Report- Forecast to 2023 | MRFRYeast Infection Market is expected to grow at CAGR of 5.2% during 2017 to 2023, Global Yeast Infection Industry categorizes the Global Market by pathogen, types, treatment and end users | Yeast Infection Market | MRFR
marketresearchfuture.comBrain Aneurysm Treatment Market Research Report- Forecast to 2023 | MRFRBrain Aneurysm Treatment Market is expected to grow at a CAGR over ~ 5.4% from 2017 to 2023, Global Brain Aneurysm Treatment Industry categorizes the Global Market by Type, Medication, Condition and End User | Brain Aneurysm Treatment Market | MRFR
parijatak.comUpper Respiratory Tract Infection TreatmentAyurvedic Treatment For Upper Respiratory Tract Infection In Nagpur About Upper Respiratory Tract Infection: Upper respiratory tract infection (URI) is a nonspecific term used to describe acute infections involving the nose, paranasal sinuses, pharynx, larynx, trachea, and bronchi. The prototype is the illness known as the common cold, which is discussed here, in addition to pharyngitis, sinusitis, … Continue reading "Upper Respiratory Tract Infection Treatment"
marketresearchfuture.comTinea Versicolor Treatment Market Research Report Forecast till 2023 | MRFRGlobal Tinea Versicolor Treatment Market is growing continuously and expected to grow at a CAGR of 7.1% from 2017 to 2023 as Tinea versicolor treatment market: Increasing prevalence and awareness are driving the market growth which is expected to reach 1107.9 million by 2023
marketresearchfuture.comPiriformis Syndrome Market Research Report –Global Forecast to 2023| MRFRPiriformis Syndrome Market expected to reach more than 7% CAGR growth forecast period 2018-2023, Piriformis Syndrome Market Categorizes by Cause, Treatment, End-User and Region | Piriformis Syndrome Industry
openpr.comBrain Aneurysm Treatment Market Estimation 2018 by Top Leading Players - Medtronic Plc., Codman & Shurtleff, Inc., Raumedic AG, Vittamed, Sophysa Ltd., MicroPort Scientific Corporation,GmbH | Outlook 2023 â MarketResearchFuture.comPress release - Market Research Future - Brain Aneurysm Treatment Market Estimation 2018 by Top Leading Players - Medtronic Plc., Codman & Shurtleff, Inc., Raumedic AG, Vittamed, Sophysa Ltd., MicroPort Scientific Corporation,GmbH | Outlook 2023 ? MarketResearchFuture.com - published on openPR.com
openpr.comMenopause Treatment Market is Trending with CAGR of 4.2% by 2023, Key Players- Merck & Co., Inc., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Allergan plc, Emcure Pharmaceuticals Ltd. - Broadcast MRFRPress release - Market Research Future - Menopause Treatment Market is Trending with CAGR of 4.2% by 2023, Key Players- Merck & Co., Inc., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Allergan plc, Emcure Pharmaceuticals Ltd. - Broadcast MRFR - published on openPR.com
marketresearchfuture.comWhipple’s Disease Market - Global Forecast till 2023Global Whipple’s Disease Market was around USD 206.2 million in 2016 and is expected to reach USD 255.3 million by 2023 at a projected CAGR of 3.1%,Whipple’s disease market by diagnosis,by treatment,by end use | Whipple’s Disease Industry